Tariffs are the biggest macroeconomic concern for two in three investors, poll finds

Tariffs are the biggest macroeconomic concern for two in three investors, poll finds


Mounting trade tensions and tariffs have become the single biggest worry for global investors, overshadowing all other economic risks, a new survey shows.

Nearly two-thirds (63%) of institutional investors and wealth managers identified trade levies as the most significant macroeconomic concern impacting their strategy, according to a survey published by British investment manager Schroders.

The perceived risk from tariffs was more than six times greater than the next highest-ranking concern.

Made with Flourish

The poll, which surveyed nearly 1,000 top investors representing a combined $67 trillion in assets, found that this trade uncertainty is fueling a demand for stability.

The study was done between April and May, and ahead of the announcement of the trade deal that U.S. President Donald Trump said was reached with China. The agreement struck on Wednesday is subject to final approval by Trump and Chinese President Xi Jinping, the White House leader said.

Meanwhile, the Schroders survey indicated that about four in five investment professionals polled also said they are likely to increase their allocation to actively managed investments in the coming year, in a bid to stem the volatility caused by macroeconomic events.

 “Resilience now tops the investment agenda, as the rising tide no longer lifts all boats,” said Johanna Kyrklund, group chief investment officer at Schroders. “The wider backdrop is that financial markets are still adjusting back to structurally higher interest rates, made painful in many cases by high levels of debt. This is raising questions about future market trends and the value of passive approaches in a period of greater uncertainty.”

Kyrklund added, “In this environment, active strategies provide the control investors need to manage complexity, create portfolio resilience and seize opportunities.”



Source

Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval
World

Shares in Wegovy-maker Novo Nordisk pop 6% after GLP-1 pill approval

Shares in Novo Nordisk surged 6% Monday, after the Wegovy maker secured approval of its GLP-1 pill — a world first. The U.S. Food and Drug Administration’s approval of Novo Nordisk’s GLP-1 pill gives the Danish pharmaceutical giant a head start over U.S. rival Eli Lilly. The pill’s starting dose of 1.5 milligrams will be […]

Read More
Singapore consumer inflation remains steady at 1.2% in November, missing estimates
World

Singapore consumer inflation remains steady at 1.2% in November, missing estimates

An aerial view of Singapore’s Marina Bay Street Circuit on Sept. 17, 2024. Roslan Rahman | Afp | Getty Images Singapore’s inflation in November remained steady at 1.2%, missing estimates, as a higher increase in prices of services was offset by a steeper decline in electricity costs. The reading was lower than Reuters-polled analysts’ median […]

Read More
China’s second attempt at completing a reusable rocket test fails
World

China’s second attempt at completing a reusable rocket test fails

WENCHANG, CHINA – DECEMBER 20: A Long March-5 rocket carrying a new communication technology test satellite blasts off from the Wenchang Space Launch Site on December 20, 2025 in Wenchang, Hainan Province of China. China News Service | China News Service | Getty Images The first stage of China’s reusable Long March 12A “was not […]

Read More